Our work in #CCUS. #Eha25

Good meeting in #milano. Thank you #eha25 👋

Azacitidine impact on 88 #Vexas pts ⭐️ RFS was 90% for responders ⭐️ pts had TI and ⬇️ inflammation ⭐️⭐️ response takes >6 months to happen in majority ⭐️ U A1 ⬇️VAF occurred in 65%. Some had VAF <2% #EHA25 congress-distribution.ehaweb.org/from.storage?i…

LENZ/AZA seems to be effective in high risk CMML enriched with CBL and RAS mutations. 85%CR mCR. GM-CSFi. #EHA25 congress-distribution.ehaweb.org/from.storage?i…

So sad to hear this. High risk #MDS continues to be tough to conquer. Awaiting more results to understand this neg study.

Subcutaneous blinatumomab in adults with relapsed or refractory B-cell acute lymphoblastic leukaemia: post-hoc safety and activity analysis from a multicentre, single-arm, phase 1/2 trial - The Lancet Haematology thelancet.com/journals/lanha… 1. CR/CRi rate 77% in RR B-cell ALL

Biking at #Lake_Harriet #Minneapolis l

Hematologists are problem-solvers. I’m proud to join my friend and colleague Dr. Belinda Avalos (Belinda Avalos, MD) support the #Fight4Hematology to fund bold research and training that pushes our field forward. Donate Now donate.hematology.org/s/ ASH

We’re in this together. Let’s keep hematology moving forward. #Fight4Hematology Donate now. donate.hematology.org/s/

At some point, someone invested in us. Now it’s our turn. Join me in supporting the #Fight4Hematology and help secure the future of hematology research and care. ASH Foundation - Hematology.org hematology.org/foundation

At some point, someone invested in us. Now it’s our turn. Join me in supporting the #Fight4Hematology and help secure the future of hematology research and care! Support the ASH foundation hematology.org/foundation

#biking to work with electric 🛴. So much fun. #RST #Rochester

When a peripheral blood smear adds more ??? to a puzzling case 🤔 #hematology 🩸 🔬 ?

Hematologists are problem-solvers. I’m proud to support the #Fight4Hematology to fund bold research and training that pushes our field forward. donate.hematology.org/s/

Excellent read about lineage switch after immune therapy ⭐️ international study ⭐️ switch vs drift ⭐️ CART or Blina mainly ⭐️ big hits: KMT2A, complex CG, CDKN2Am, BCR::ABL, P53 ⬇️ CR at 30% ⁦Blood Journals Portfolio⁩ ashpublications.org/blood/article/…

Give if you can. Share if you believe. We need more voices in the #Fight4Hematology ⁦ASH⁩ donate.hematology.org/s/

Our wonderful Summer Research Experience at ⁦Georgia Cancer Center⁩ for high school students, investing in our future scientists and leaders. jagwire.augusta.edu/future-scienti…

Today is ASH #ASH25 annual meeting abstract submission deadline, the day each year in which we celebrate hematology research productivity.😀 To help support future hematology research & education, consider donating to non-profit ASH Foundation hematology.org/foundation

Inspiring lecture by #Robin_Roberts today. “Dream Big”…. 👏 👏 And yes 👠 were fabulous 😆 #GMA #MayoClinic #Leadership_Lectures

ENHANCE-2 study in P53+ AML 2 randomizations: Magro_AZA vs Ven_AZA Magro_AZA vs 7+3 ⭐️ magro_AZA did not improve OS ⭐️ magro_AZA did not have higher ORR ⭐️⭐️ OS was really low in all arms We need novel drugs for p53 mutated MN ashpublications.org/blood/article/…